Status:
COMPLETED
Amlodipine 10mg Drug Use Investigation
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Hypertension
Eligibility:
All Genders
20+ years
Brief Summary
In this survey, to collect the safety and efficacy information in the subjects who have been treated with amlodipine 5mg at least 4 weeks in daily practice.
Detailed Description
All the subjects whom an investigator prescribes Amlodipine (Norvasc®) 10mg Tablet should be registered consecutively until the number of subjects reaches target number in order to extract patients en...
Eligibility Criteria
Inclusion
- Male or female subjects who have been treated with amlodipine 5mg at least 4 weeks
- The subjects who had not achieved target BP
Exclusion
- Subjects who have been prescribed amlodipine (Norvasc®) 10mg Tablet before
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
14141 Patients enrolled
Trial Details
Trial ID
NCT01252563
Start Date
December 1 2010
End Date
October 1 2012
Last Update
January 28 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.